Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy

Minimal hepatic encephalopathy (MHE) is frequently diagnosed in patients with liver cirrhosis who do not show overt clinical cirrhosis-associated neurological deficits. This condition manifests primarily with visuo-motor and attention deficits. We studied the association between visuo-motor deficits and magnetic resonance spectroscopic parameters in cingulate grey matter and white matter of centrum semiovale in patients with liver cirrhosis. The data revealed an increase in the glutamate–glutamine/creatine ratio and a decrease in choline/creatine and inositol/creatine ratios in patients with liver cirrhosis. The analysis of the data showed that cirrhosis-associated deterioration of the visuo-motor function significantly correlates with a decrease in the choline/creatine ratio and an increase in N-acetylaspartate/choline in cingulate grey matter but not in the neighbouring white matter. Furthermore, the increase in the glutamate–glutamine/creatine ratio correlated significantly with the increase in the N-acetylaspartate/creatine ratio. These data suggest an association between altered choline, glutamate-glutamine and NAA metabolism in cingulate grey matter and symptoms of MHE, and underline the importance of differentiation between grey and white matter in magnetic resonance spectroscopic studies on patients with cirrhosis-associated brain dysfunction.

[1]  Christian Kremser,et al.  Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy , 2003, NeuroImage.

[2]  A. Falini,et al.  In vivo neurochemistry with emission tomography and magnetic resonance spectroscopy: clinical applications , 2002, European Radiology.

[3]  W. Poewe,et al.  Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6 , 2001, Journal of magnetic resonance imaging : JMRI.

[4]  À. Rovira,et al.  Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. , 2001, AJNR. American journal of neuroradiology.

[5]  Peter Andersen,et al.  Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T , 2004, Magnetic resonance in medicine.

[6]  À. Rovira,et al.  CASE REPORT: Usefulness of Magnetic Resonance Spectroscopy for Diagnosis of Hepatic Encephalopathy in a Patient with Relapsing Confusional Syndrome , 2001, Digestive Diseases and Sciences.

[7]  A. Haley,et al.  Molality as a unit of measure for expressing 1H MRS brain metabolite concentrations in vivo. , 2003, Magnetic resonance imaging.

[8]  W. Hop,et al.  Screening of subclinical hepatic encephalopathy. , 2000, Journal of hepatology.

[9]  À. Rovira,et al.  1H Magnetic Resonance in the Study of Hepatic Encephalopathy in Humans , 2002, Metabolic Brain Disease.

[10]  A. Lockwood,et al.  Early detection and treatment of hepatic encephalopathy. , 1998, Current opinion in neurology.

[11]  O. Selnes.  A Compendium of Neuropsychological Tests , 1991, Neurology.

[12]  Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging , 1997, Hepatology.

[13]  B D Ross,et al.  Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. , 1994, Radiology.

[14]  J. Kulisevsky,et al.  Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  K Weissenborn,et al.  Neuropsychological characterization of hepatic encephalopathy. , 2001, Journal of hepatology.

[16]  R. Butterworth.  Pathophysiology of Hepatic Encephalopathy: A New Look at Ammonia , 2002, Metabolic Brain Disease.

[17]  C. Jack,et al.  Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. , 2003, AJNR. American journal of neuroradiology.

[18]  J. Neale,et al.  Biosynthesis of NAAG by an enzyme‐mediated process in rat central nervous system neurons and glia , 2004, Journal of neurochemistry.

[19]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[20]  J. Frahm,et al.  On the identification of cerebral metabolites in localized 1H NMR spectra of human brain In vivo , 1991, NMR in biomedicine.

[21]  J. Frahm,et al.  Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS , 1997, NMR in biomedicine.

[22]  Hartmut Hecker,et al.  Memory function in early hepatic encephalopathy. , 2003, Journal of hepatology.

[23]  C. Clarke,et al.  Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes , 2001, European journal of neurology.

[24]  A. Lockwood,et al.  Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998 , 2002, Hepatology.

[25]  B D Ross,et al.  Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. , 1992, Radiology.

[26]  S. Bluml,et al.  Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? , 1996, Digestive diseases.

[27]  G. Sutherland,et al.  Labeling of N-acetylaspartate and N-acetylaspartylglutamate in rat neocortex, hippocampus and cerebellum from [1-13C]glucose , 1998, Neuroscience Letters.

[28]  V. Felipo,et al.  Effects of Hyperammonemia and Liver Failure on Glutamatergic Neurotransmission , 2002, Metabolic Brain Disease.

[29]  S. Taylor-Robinson,et al.  Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy , 1994, Metabolic Brain Disease.

[30]  K. Weissenborn,et al.  Attention Deficits in Minimal Hepatic Encephalopathy , 2001, Metabolic Brain Disease.

[31]  H. Schomerus,et al.  Neuropsychological Aspects of Portal-Systemic Encephalopathy , 1998, Metabolic Brain Disease.

[32]  J. Neale,et al.  N‐Acetylaspartylglutamate , 2000, Journal of neurochemistry.

[33]  S. Nelson,et al.  3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain. , 2002, Magnetic resonance imaging.

[34]  U. Klose,et al.  MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. , 2000, Radiology.

[35]  P. Hayes,et al.  Diagnosis of hepatic encephalopathy: Will in vivo proton MRS play a role? , 1999, Hepatology.

[36]  H. Hinterhuber,et al.  Incomplete improvement of visuo‐motor deficits in patients with minimal hepatic encephalopathy after liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.